We have inserted into a retroviral vector the structural information encoding the selectable bacterial genes neo and gpt linked, respectively, to the promoters of the herpesvirus thymidine kinase gene and the rat preproinsulin II gene. We have used this recombinant retrovirus construction to transduce insulinoma cell lines that are positive or negative for insulin expression. Selection of the transductants for neo yielded resistant colonies from all of the cell lines, while selection for gpt yielded resistant transductants in relatively high frequency only from insulin-producing cells. The 5' end of the gpt transcripts maps to the authentic preproinsulin capping site of the construction.
preproinsulin II gene promoter.
We show that selection for gpt yields resistant colonies in relatively high frequency only in insulin-producing cells, while neomycin-resistant transductants were isolated from all of the cell lines tested.
MATERIALS AND METHODS
Recombinant DNAs. Fig. 1 shows the construction pVD4 that we used to transform (by the calcium phosphate precipitation method) clone 4 cells (a Moloney murine leukemia provirus-producing derivative of the 3T3 cell line) to produce a mixture of wild-type (helper) and recombinant packaged retrovirus that was used, in turn, for gene transfer, by infection, into the insulinoma cell lines. pVD4 was constructed in two steps. We first cloned into the unique Xho I site of the retroviral vector pV200, a 1.55-kilobase (kb) Sal I fragment containing the viral tk promoter connected to the body of the bacterial gene neo, which confers resistance to the aminoglycoside antibiotic G418 in eukaryotic cells (13) . The recombinant we selected (pV200neo) has the tk promoter in the same transcriptional orientation as the long terminal repeat (LTR) promoters, and it is a new vector with a unique Bam cloning site. In a second step, we cloned into this site a 2.45-kb Bam fragment containing the rat preproinsulin II gene promoter connected to the body of the E. coli gpt gene and selected the recombinant pVD4, in which the insulin and LTR promoters are in opposite orientations, to assure exclusive assay of the insulin gene promoter.
The original vector pV200 (provided by S. Brigham and S. Goff) consists of a 4.25-kb EcoRI fragment inserted into the EcoRI site of a Bam-tetracycline-sensitive pBR322 derivative. The insert is a deletion mutant of a Moloney murine leukemia provirus (2.22 kb of viral sequence flanked by rat chromosomal DNA) (12) . A proviral sequence between the Pst and Hpa I sites has been eliminated, and the sites have been converted to Xho I sites. Thus, the ATG initiator of the gag gene has been eliminated, while the polyadenylylation signal of the viral RNA has been retained in the right LTR.
The Sal I tk-neo fragment was derived as follows. We first cloned into the unique Bgl II site of the tk gene in plasmid (24) and assayed by Southern blotting (25) . Total cell RNA was purified by the guanidine thiocyanate/CsCl procedure (26) and analyzed by S1 nuclease protection (27) , using homogeneously labeled single-stranded probes synthesized from M13 templates by a modification of published procedures (28) . RESULTS
Levels of Preproinsulin mRNA in Rat Insulinoma Cell
Lines. Fig. 3 . Since these are mass cultures of hundreds of independent clones, rearranged inserts occurring in only one or a few of the clones would be invisible by this analysis. However, the following arguments suggest that the majority of the inserted recombinant proviruses are present in a form colinear with the proviral insert of pVD4. Retroviral vectors of this type are usually inserted as one copy per cell (30, 31) . This is indeed the case for each of three clones of transduced NIH 3T3 cells we examined (data not shown). Thus, a single copy of the tk-neo gene is sufficient to confer G418 resistance to mouse cells, and presumably to rat cells as well. Since the proportion of rat cells that acquired resistance was quite low, it is reasonable to assume that most of the rat cell colonies contain a single inserted recombinant provirus.
Assuming that one recombinant is present per transduced drug-resistant cell, we can estimate the proportion of nonrearranged inserts in the mass culture by comparing in Fig. 3 the intensity of the provirus band with that of an endogenous preproinsulin gene band. The probe for this blot was the 2.45-kb Bam insulin-gpt fragment in pVD4 (Fig. 1) , a third of which (755 bp) belongs to insulin sequence. Thus, a single nonrearranged proviral insert in each rat cell, which contains two rat preproinsulin genes, would yield a ratio of retrovirus/endogenous band intensities of 1.5 (3/1 for probe lengths x 1/2 for copy number). The observed ratio is close to this number. Comparison of the pattern of Bam digestion with the one using Sst I (which cuts the recombinant provirus twice, once in each LTR) shows that virtually all of the proviral inserts that contain the intact insulin-gpt fragment con- (Fig. 1) . The DNA digests, electrophoresed on an 0.8% agarose gel, were as follows: lanes 1 and 5, rat insulinoma DNA (control); lanes 2 and 6, n38VDm DNA; lanes 3 Fig. 1 , and a second site -1 kb to the right of the first one. In some cases there are small differences in the mobility of the same band in different lanes, due to the electrophoretic conditions. The bands corresponding to the second endogenous rat preproinsulin gene (gene I) are not detected in this blot because of very stringent hybridization and washing conditions. tain an entire recombinant provirus with their LTR-to-LTR distance identical to that in pVD4.
RNA Transcripts of the Transduced Cell Lines. The B6 cells contain small levels of insulin mRNA. Thus, it was conceivable that our failure to detect B6 XAT-resistant transductants was simply a matter of statistics. For this reason, we compared transcripts of the G418-resistant mass cultures n38VDm and nB6VDm with those of n3T3VDm control RNA. Fig. 4A shows the results of S1 nuclease mapping of total RNA extracted from the three mass cultures, using a uniformly labeled single-stranded probe containing insulin-gpt sequences. A protected-probe band of 176 nt would correspond to a spliced transcript originating at the preproinsulin cap site and extending through the Sau3A site in the gpt cod- ing sequence. This is exactly the size of the band protected by the n38VDm RNA (lane 2). A band of the same size also appeared in the nB6VDm lane, following over-exposure of the same gel (lane 3), while the n3T3VDm RNA did not protect the probe at all (lane 1). We note, however, that the intensity of the protected-probe band by nB6VDm RNA (Fig. 3A, lane 3) is close to background levels (compare with lanes 3' and 1). Several attempts (using a variety of conditions) to visualize the predicted 53-nt fragment protected by the endogenous mRNA in these experiments were unsuccessful, probably because of instability of this particular hybrid. Preliminary data suggest that the steady-state level of the hybrid insulin-gpt transcript in the transduced insulinoma cells is significantly lower than the level of the endogenous insulin mRNA. We do not know the reason(s) for this difference. Except for the possibility that the hybrid transcript may be unstable, we note that the insulin promoter of the construction is present in the transductants in a radically different chromosomal environment than the endogenous gene promoter. In addition, the strong LTR promoter is efficiently transcribing through the insulin promoter region, which is facing in the opposite direction.
The same RNA preparations (from n38VDm, nB6VDm, and n3T3VDm cultures) were used to examine transcripts of the tk-neo selectable marker, using the same approach and a tk probe (Fig. 3B) . Transcripts originating at the tk cap site can protect only 56 nt of this probe. However, all three RNA preparations protect 131 nt, which correspond to all of the probe sequences upstream from the +56 tk Bgl II site (including sequences upstream from the cap). Presumably, the transcripts protecting these upstream sequences originate from the upstream LTR promoter. The almost equal intensity of the 131-nt band protected by n38VDm and nB6VDm RNAs strengthens our conclusion from the previous experiment concerning differential recognition of the insulin promoter in 38 and B6 cells, because the retroviral promoter is recognized equally by the transcriptional apparatus in both cases, as expected.
An interesting and unexpected result was the appearance, predominantly in the n38VDm RNA, of transcripts originat- 
DISCUSSION
The rat insulinoma cell lines we used in these studies are closely related. They were derived from the same tumor and they are similar morphologically. In addition, the patterns of their 35S-labeled proteins on high-resolution two-dimensional gels are nearly identical (unpublished results). Moreover, B6 cells, which do not produce detectable levels of insulin, contain, at a low level, preproinsulin mRNA transcripts. They also seem to recognize and utilize the exogenous insulin gene promoter, but their output of steady-state transcripts is very inefficient compared with that of the insulinproducing 38 cells. We think that the simplest interpretation of our results is that both cell lines contain different amounts of trans-acting insulin gene-specific factors.
It is still possible to argue from these results that the putative trans-acting factors affect mRNA stability (if one ac-cepts that their site of action resides in the only 53 nt of insulin mRNA remaining in the fused insulin-gpt transcripts). We speculate, however, that the factors act, at least in part, at the transcriptional level. This is because the pattern of relative abundance of the endogenous and exogenous insulin gene transcripts (higher in 38 and lower in B6 cells) extends to that fraction of the tk-neo transcripts that initiates at the tk capping site. This observation is most consistent with the hypothesis of transcriptional activation (although we have not proven rigorously that the phenomenon is caused by the insulin sequences present in the construction). We note, in addition, that tissue-specific expression of the rat preproinsulin II gene in the insulinoma tumor, from which the cell lines we used were derived, correlates with the presence of a DNase I-hypersensitive site in the 5' gene flanking region (32) . The presence of such hypersensitive sites is consistent only with transcriptional control (assuming, of course, that correlations between nuclease hypersensitivity and expression are not merely coincidental). This hypothesis is strengthened by the fact that a tissue-and developmentalstage-specific DNA-binding factor conferring nuclease hypersensitivity to the 5' flanking region of the adult chicken p8-globin gene has been described recently (33) .
Assuming that transcriptional factors are involved, they appear to recognize in our system control elements on the DNA of the newly introduced cloned insulin sequences (which did not undergo a differentiation process), in a fashion analogous to their action on the endogenous genes. Though this result is not altogether surprising, it does rule out possible models in which the insulin gene is modified early in development by rearrangement, mutation, demethylation, or inheritable chromatin structure, and progeny cells inherit the pattern of gene expression by inheriting the modification. The result also implies that the genes of the transacting factors or the factors themselves are recognized and modulated by signals during developmental commitment.
The key feature of this work is that we have placed a dominant selectable marker under insulin gene control. Thus, we have produced a genetic tool that can be used for a rescuetype experiment, to identify and study the sequences encoding the postulated trans-acting factors that control insulin gene expression in these cell lines. Specifically, an expressing cDNA library from 38 cell mRNA in a retroviral vector can be constructed and introduced into the G418-resistant/XAT-sensitive B6 or 44 cells that we describe in this paper. Any resulting gpt' colonies would presumably contain cloned cDNAs encoding trans-acting factors.
Our approach reemphasizes the applicability of retroviral vectors as effective transducing agents, because they can be used for gene transfer into highly differentiated cells (such as the insulinoma cell lines) that take up calcium phosphateprecipitated DNA poorly. In our case, they also drive into chromosomal integration a complex construction without rearrangement. The same vectors can be pseudotyped by many different wild-type retroviruses (34), increasing enormously the range of transducible cells. In this respect, our Bam vector pV200neo is a general one, which can be used for the insertion of any gene promoter connected to gpt or an equivalent selectable marker, to be used in other cultured cell systems.
